CD7 and acute lymphoblastic leukemia: For example, the UCART7 product for CD7+ acute lymphocytic leukemia (ALL) uses clustered regularly interspaced palindromic repeat (CRISPR)/Cas9 editing to simultaneously eliminate the endogenous T cell receptor alpha constant (TRAC) and CD7 genes, preventing GVHD and fratricide, respectively (32).